Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | TAK | UTHR | ||
| Company | Neurocrine Bioscienc | Takeda Pharmaceutical Ltd ADR | United Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 136.05 | 13.15 | 234.76 | ||
| High | 139.37 | 13.19 | 240.93 | ||
| Low | 136.05 | 13.11 | 234.76 | ||
| Last | 138.89 | 13.17 | 238.26 | ||
| Change | +2.90 | +0.14 | +4.41 | ||
| % Change | +2.13% | +1.07% | +1.89% | ||
| Volume | 681,700 | 1,333,100 | 496,500 | ||
| 20-Day Average Volume | 750,080 | 1,757,815 | 477,120 | ||
| Previous Close | 135.99 | 13.03 | 233.85 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 136.34 | 13.36 | 234.98 | ||
| 20-Day Raw Stochastic | 58.91% | 21.43% | 80.25% | ||
| 20-Day Relative Strength | 53.59% | 37.46% | 54.06% | ||
| Weighted Alpha | +42.59 | -21.79 | +11.10 | ||
| Today's Opinion | 80% Buy | 100% Sell | 80% Buy | ||
| Previous Opinion | 48% Buy | 100% Sell | 64% Buy | ||
| Last Month's Opinion | 88% Buy | 72% Sell | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.91% since 04/22/24 | -1.42% since 04/22/24 | +1.79% since 04/22/24 | ||
| Low | 135.17 on 04/26/24 | 13.01 on 04/26/24 | 233.27 on 04/24/24 | ||
| High | 145.00 on 04/23/24 | 13.41 on 04/23/24 | 241.00 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | +0.70% since 03/28/24 | -5.18% since 03/28/24 | +3.72% since 03/28/24 | ||
| Low | 130.13 on 04/19/24 | 13.01 on 04/26/24 | 221.53 on 04/01/24 | ||
| High | 145.00 on 04/23/24 | 13.78 on 04/01/24 | 241.37 on 04/11/24 | ||
| 3-Month | |||||
| %Chg | -2.34% since 01/29/24 | -10.83% since 01/29/24 | +9.84% since 01/29/24 | ||
| Low | 128.00 on 02/07/24 | 13.01 on 04/26/24 | 208.62 on 02/08/24 | ||
| High | 148.37 on 03/21/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | ||
| 6-Month | |||||
| %Chg | +30.94% since 10/27/23 | -2.23% since 10/27/23 | +8.68% since 10/27/23 | ||
| Low | 103.63 on 11/10/23 | 13.01 on 04/26/24 | 208.62 on 02/08/24 | ||
| High | 148.37 on 03/21/24 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,531,958 | 41,237,580 | 11,004,745 | ||
| Shares Outstanding, K | 99,507 | 3,164,818 | 47,059 | ||
| Annual Sales | 1,887,100,000 | 29,803,340,000 | 2,327,500,000 | ||
| Annual Net Income | 249,700,000 | 2,345,930,000 | 984,800,000 | ||
| Last Quarter Sales | 515,200,000 | 7,556,070,000 | 614,700,000 | ||
| Last Quarter Net Income | 147,700,000 | 718,900,000 | 217,100,000 | ||
| 60-Month Beta | 0.25 | 0.53 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.44 on 02/07/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | ||
| Latest Earnings Date | 05/01/24 | 05/09/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | 0.261 on 09/28/23 | N/A | ||
| Next Ex-Dividends Date | N/A | 09/28/23 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 56.93 | 6.70 | 11.89 | ||